At this pan-tumor, interactive symposium, discussions will encompass the latest topics in major solid and liquid tumors. This meeting will cover key ..
malignancies, including lung cancers, breast cancers, gastrointestinal cancers, genitourinary cancers, skin cancers, and hematologic malignancies, and feature keynote lectures focusing on precision medicine. High-impact sessions will focus on practical takeaways regarding the latest updates in next-generation sequencing, liquid biopsy, and cytogenetic testing. The expert faculty will review updates in targeted treatment, including tumor-agnostic indications based solely on genomic markers and other biomarkers. This program will emphasize the role of advanced genetic panel testing and the use of targeted therapies, as well as best practices for leveraging relevant actionable targets that drive clinical decision making, with a focus on data that is most relevant for patient care.